Posted in | News | Nanobusiness

Nanobac Pharmaceuticals Diagnostic Testing Services to be Available by End of Month

Oct 3 2007

Related Stories

Nanobac Pharmaceuticals Inc. is pleased to announce that its diagnostic test, NB2, being offered through an agreement with American Health Associates (AHA) will be available by late October. Parties interested in getting tested are encouraged to start the specimen collection process as AHA is ready to receive NB2 specimens.

“We are extremely excited to make our diagnostic test available to patients and physicians in the United States as we had discussed in our investor conference call,” stated Alex H. Edwards III, Director, Nanobac Pharmaceuticals. “This is the first step in creating awareness of the NB2 test's utility in the Diagnosis and Management of patients with a multitude of diseases, and is the start of acceptance as a standard of care in healthcare,” Edwards concluded.

Nanobac Pharmaceuticals Inc. is headquartered in Tampa, Florida. Information on how to obtain an NB2 test is available at www.nanobac.com .

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback